Protalix BioTherapeutics
PLX
#8931
Rank
โ‚ฌ0.16 B
Marketcap
2,08ย โ‚ฌ
Share price
0.42%
Change (1 day)
54.64%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): 0,18ย โ‚ฌ

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is 0,18ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,07005ย โ‚ฌ a decrease over its 2024 EPS that were of 0,03502ย โ‚ฌ.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)0,18ย โ‚ฌ-354.2%
2025-0,07005ย โ‚ฌ-300%
20240,03502ย โ‚ฌ-66.67%
20230,11ย โ‚ฌ-138.71%
2022-0,27ย โ‚ฌ-50%
2021-0,54ย โ‚ฌ181.82%
2020-0,19ย โ‚ฌ-82.11%
2019-1,08ย โ‚ฌ-31.67%
2018-1,58ย โ‚ฌ-72.31%
2017-5,69ย โ‚ฌ124.14%
2016-2,54ย โ‚ฌ-147.54%
20155,34ย โ‚ฌ-290.63%
2014-2,80ย โ‚ฌ6.67%
2013-2,63ย โ‚ฌ130.77%
2012-1,14ย โ‚ฌ-69.77%
2011-3,77ย โ‚ฌ19.44%
2010-3,15ย โ‚ฌ-12.2%
2009-3,59ย โ‚ฌ36.67%
2008-2,63ย โ‚ฌ-37.5%
2007-4,20ย โ‚ฌ50%
2006-2,80ย โ‚ฌ3.23%
2005-2,71ย โ‚ฌ138.46%
2004-1,14ย โ‚ฌ-74%
2003-4,38ย โ‚ฌ-0%
2002-4,38ย โ‚ฌ-50%
2001-8,76ย โ‚ฌ233.33%
2000-2,63ย โ‚ฌ-83.59%
1999-16,01ย โ‚ฌ-24%
1998-21,07ย โ‚ฌ-600%
19974,21ย โ‚ฌ-16.67%
19965,06ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,15ย โ‚ฌ 523.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
5,88ย โ‚ฌ 3,095.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-0,09632ย โ‚ฌ-152.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,20ย โ‚ฌ 552.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel